Multiple Sclerosis: Pathology

Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the CNS, resulting in symptoms including optic neuritis and motor weakness. Here is the latest research on pathology of this complex neurodegenerative disease.

August 6, 2020
Case Report
Open Access

Spinal meningioma in a patient with multiple sclerosis

Surgical Neurology International
Sricharan GopakumarJacob Mandel
July 1, 2020
Review
Open Access

Dopamine: an immune transmitter

Neural Regeneration Research
Sarah Thomas BroomeAlessandro Castorina
August 6, 2020

Diagnosis of depression in multiple sclerosis is predicted by frontal-parietal white matter tract disruption

Journal of Neurology
Kira AshtonMichael G Dwyer
June 25, 2020
Open Access

Molecular signature of slowly expanding lesions in progressive multiple sclerosis

Brain : a Journal of Neurology
Katharina JäckleWolfgang Brück
August 1, 2020
Open Access

Connecting Immune Cell Infiltration to the Multitasking Microglia Response and TNF Receptor 2 Induction in the Multiple Sclerosis Brain

Frontiers in Cellular Neuroscience
Caterina VeroniCristina Agresti
June 20, 2020

Acoustic Speech Analytics Are Predictive of Cerebellar Dysfunction in Multiple Sclerosis

The Cerebellum
Gustavo NoffsAnneke van der Walt
August 9, 2020

Large-scale informatic analysis to algorithmically identify blood biomarkers of neurological damage

Proceedings of the National Academy of Sciences of the United States of America
Grant C O'ConnellJulia H C Chang
August 12, 2020

Autofluorescence spectroscopy as a proxy for chronic white matter pathology

Multiple Sclerosis : Clinical and Laboratory Research
Megan L MorganAndrew V Caprariello
July 2, 2020
Review
Open Access

Neutrophils: Underestimated Players in the Pathogenesis of Multiple Sclerosis (MS)

International Journal of Molecular Sciences
Mirre De BondtSofie Struyf
July 2, 2020
Open Access

Synaptic Loss in Multiple Sclerosis Spinal Cord

Annals of Neurology
Natalia PetrovaKlaus Schmierer
July 29, 2020
Open Access

CD36-mediated uptake of myelin debris by macrophages and microglia reduces neuroinflammation

Journal of Neuroinflammation
Elien GrajchenJeroen F J Bogie
June 15, 2020
Review

Aquatic Therapy in Contemporary Neurorehabilitation: An Update

PM & R : the Journal of Injury, Function, and Rehabilitation
Bruce E Becker
August 1, 2020
Review
Open Access

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders

Frontiers in Medicine
Federica SaponaroGrazia Chiellini
July 11, 2020
Open Access

Motoneuron expression profiling identifies an association between an axonal splice variant of HDGF-related protein 3 and peripheral myelination

The Journal of Biological Chemistry
Bilal Ersen KermanFred H Gage
July 2, 2020
Open Access

Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex

Annals of Clinical and Translational Neurology
Hannah E SalapaMichael C Levin
July 17, 2020

Synaptic and complement markers in extracellular vesicles in multiple sclerosis

Multiple Sclerosis : Clinical and Laboratory Research
Pavan BhargavaDimitrios Kapogiannis

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

© 2020 Meta ULC. All rights reserved
/feed-previews/multiple-sclerosis-pathology/e735ddd1-f274-4676-bbfb-8a69d9a5f206